医学
安慰剂
中止
甲状腺机能正常
临床终点
背景（考古学）
内科学
不利影响
复视
甲状腺
随机对照试验
外科
病理
生物
古生物学
替代医学
作者
Raymond S. Douglas,Steven M. Couch,Sara T. Wester,Brian Fowler,Catherine Y. Liu,Prem S. Subramanian,Rosa A. Tang,Quang T. Nguyen,Robi N. Maamari,Shoaib Ugradar,Kate Hsu,M Karon,Marius N. Stan
标识
DOI：10.1210/clinem/dgad637
摘要
Early inflammatory thyroid eye disease (TED) can lead to symptomatic chronic disease, including disabling proptosis. Teprotumumab, an insulin-like growth factor-1 receptor (IGF-1R) inhibitor, previously demonstrated efficacy in acute, high-inflammation TED trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI
许甜甜鸭
冰魂
sunyz
cdercder
SYLH
个性归尘
nozero
丰知然
从容芮
jenningseastera
懵懂的采梦
iNk
Billy
乐乐乐乐乐乐
OCDer
HEIKU
难过板栗
昏睡的蟠桃
pluto
MX
皖公网安备34019202002308
